July 23, 2026

Best At-Home Migraine Neuromodulation Devices for 2026

Migraine affects more than 1 billion people worldwide. For people who want a drug-free option that can be used at home, FDA-cleared noninvasive neuromodulation devices offer several approaches to acute or preventive migraine treatment.

Depending on the product, a device may be worn on the forehead or arm, positioned around the head, or held against the neck or back of the head during treatment. The devices also differ by stimulation mechanism, age indication, prescription status, treatment format, and cleared use.

This guide reviews several FDA-cleared neuromodulation devices available for at-home migraine treatment in 2026. It focuses on practical product differences rather than comparing competitor clinical trials or evidence quality.

Key Takeaways

Several FDA-cleared options are available: At-home migraine devices use mechanisms such as external trigeminal nerve stimulation, remote electrical neuromodulation, noninvasive vagus nerve stimulation, transcranial magnetic stimulation, and other forms of transcutaneous electrical stimulation.
Cefaly combines acute and preventive treatment: The reusable forehead device provides a 60-minute Acute program and a 20-minute daily Prevent program for adults.
Cefaly is prescription-free: It is available without a prescription in the U.S., Canada, the EU, and other countries.
Access requirements vary: Some devices are available over the counter, while others require a prescription or access through a healthcare program.
Safety information is device-specific: Every product has its own warnings, contraindications, and instructions for use.

Understanding At-Home Neuromodulation for Migraine

Neuromodulation uses controlled electrical or magnetic energy to influence nerve activity involved in migraine. These devices are noninvasive, meaning they do not require an implant or injection.

Common Neuromodulation Approaches

FDA-cleared migraine devices use several mechanisms:

External trigeminal nerve stimulation (e-TNS): Stimulates branches of the trigeminal nerve through the forehead.
Remote electrical neuromodulation (REN): Applies electrical stimulation to the upper arm to activate pain-regulation pathways.
Noninvasive vagus nerve stimulation (nVNS): Delivers stimulation to the vagus nerve through the side of the neck.
Single-pulse transcranial magnetic stimulation (sTMS): Applies brief magnetic pulses at the back of the head.
Transcutaneous electrical nerve stimulation: Uses skin-level electrodes to stimulate selected nerve pathways.

Why People Consider Drug-Free Devices

A neuromodulation device does not add another medication to a treatment routine. This can be relevant for people who prefer a non-pharmaceutical option, cannot tolerate certain medications, or want an additional tool to discuss with a healthcare provider.

Benefits and risks should not be generalized across the entire category. Each device has different indications, contraindications, treatment instructions, and access requirements. A healthcare provider can help determine how a device may fit into an individualized migraine treatment plan.

1. Cefaly

Best For: Adults seeking one reusable, prescription-free device for both acute and preventive migraine treatment

Age Indication: 18+

Prescription: Not required

Current U.S. Price: $509 for Cefaly Connected

Cefaly became the first FDA-cleared device for migraine prevention in 2014, received FDA clearance for acute migraine treatment in 2017, and became available over the counter in the U.S. in 2020. It uses external trigeminal nerve stimulation to target the trigeminal nerve, the primary pathway involved in migraine pain.

How Cefaly Works

The Cefaly device attaches magnetically to a reusable adhesive electrode positioned on the forehead, between and just above the eyebrows. The device delivers precise electrical impulses through the skin to stimulate trigeminal nerve endings.

Cefaly provides two treatment programs:

Acute program: A 60-minute session used during a migraine attack
Prevent program: A 20-minute session used daily for preventive treatment

Cefaly is FDA-cleared for the acute treatment of migraine with or without aura and for preventive treatment in adults.

Cefaly Connected

Cefaly Connected is the current device listed on Cefaly’s U.S. website. It combines both treatment programs with Bluetooth connectivity to the Cefaly Migraine Relief app.

Connected features include:

Program selection through the app
Real-time session monitoring
Intensity adjustment
Treatment and migraine logging
Personalized reports for healthcare discussions
Integration with Apple Health, Google Health, Fitbit, Oura, Garmin, and other supported platforms

Product and service availability varies by region. Cefaly Connected, the Cefaly Migraine Relief app, and Cefaly coaching are not currently available in the EU.

Cefaly Clinical Evidence

Cefaly is supported by more than 20 years of research, more than 12 clinical trials, 18 peer-reviewed publications, and three pivotal randomized controlled trials. Cefaly’s clinical studies report the following outcomes:

ACME Study:

79% of patients experienced a significant reduction in headache pain after one hour of Acute treatment.
63% reported that one hour of treatment reduced their pain by half or more.

TEAM Study:

56.4% reported resolution of their most bothersome migraine symptom after two hours of treatment.
67.3% of patients who identified nausea as their most bothersome symptom reported that it resolved.
42.5% reported resolution of all migraine symptoms after two hours.

PREMICE Study:

Patients had a 32.7% decrease in headache days after three months of compliant Prevent treatment.
Patients had a 36.6% decrease in acute migraine medication intake after three months.

Why Cefaly Stands Out

Cefaly offers several practical advantages for adults managing migraines at home:

Prescription-free access: Cefaly is available without a prescription in the U.S., Canada, the EU, and other countries.
Two treatment programs: Acute and Prevent programs are included in one reusable device.
Established research history: Cefaly has been studied for both acute and preventive migraine treatment.
Direct-purchase protection: Eligible products purchased from the official website can be returned under the 90-day return policy.
Healthcare spending options: The device and electrodes may qualify for HSA/FSA eligibility, subject to plan rules.
Support resources: Users can access app tools, free coaching in supported regions, customer support, and a network of certified providers.

2. Enso for Migraine

May Suit: Adults accessing migraine care through an eligible Hinge Health program

Age Indication: 18+

Prescription: Not required under its FDA clearance

Enso for Migraine received FDA clearance on April 16, 2026. The FDA identifies it as an over-the-counter, app-controlled wearable system for the acute treatment of migraine with or without aura and preventive treatment in adults.

The system uses transcutaneous electrical nerve stimulation delivered through a gel pad attached to the skin. Current access is tied to Hinge Health’s Migraine Care program, so program and benefit eligibility may affect availability.

3. Nerivio

May Suit: Children, adolescents, or adults who prefer an upper-arm wearable

Age Indication: 8+

Prescription: Required

Nerivio uses remote electrical neuromodulation through an armband worn on the upper arm. A smartphone app controls stimulation intensity and treatment sessions.

The device is FDA-cleared for acute and preventive treatment of migraine with or without aura in patients age 8 and older. It is used at the onset of migraine for acute treatment or every other day for preventive treatment.

4. gammaCore

May Suit: Patients prescribed a handheld neck-applied device

Age Indication: 12+

Prescription: Required

gammaCore delivers noninvasive vagus nerve stimulation through the side of the neck. Treatment is administered through two-minute stimulations, with the number and timing of stimulations determined by the applicable treatment protocol.

The device is FDA-cleared for acute and preventive migraine treatment in patients age 12 and older. It also has separate indications for certain other headache disorders.

5. SAVI Dual

May Suit: Patients interested in a magnetic stimulation device without adhesive forehead electrodes

Age Indication: 12+

Prescription: Required

SAVI Dual is a portable, handheld single-pulse transcranial magnetic stimulation device. It delivers a brief magnetic pulse to the back of the head and is FDA-cleared for acute and preventive treatment of migraine in adolescents age 12 and older and adults.

People who are pregnant or breastfeeding should talk to their healthcare provider before using any neuromodulation device.

6. Relivion MG

May Suit: Adults prescribed a headset-style device for acute treatment

Age Indication: 18+

Prescription: Required

Relivion MG is a headset-style transcutaneous electrical nerve stimulation device. It uses three pairs of electrodes positioned at the forehead and occiput to stimulate trigeminal and occipital nerve branches.

The device is FDA-cleared for acute migraine treatment with or without aura in adults. A treatment session runs for up to 60 minutes, and an optional provider interface can support treatment follow-up.

7. HeadaTerm 2

May Suit: Adults researching an over-the-counter forehead device for prevention

Age Indication: 18+

Prescription: Not required

HeadaTerm 2 is an over-the-counter transcutaneous electrical nerve stimulation device placed on the forehead. FDA documentation identifies it for the preventive treatment of episodic migraine in adults.

Its FDA-cleared indication is preventive rather than acute, so users should review the product instructions carefully before selecting it for a treatment goal.

Cefaly Safety, Side Effects, and Contraindications

Safety information should be evaluated for each specific device. Cefaly’s clinical evidence should not be used to make class-wide claims about every neuromodulation product.

Reported Cefaly Safety Findings

Cefaly clinical studies reported no serious adverse effects associated with Cefaly treatment. Reported side effects were generally minor and reversible when treatment stopped.

Cefaly lists the following side effects:

Common: Sleepiness or headache after a session
Uncommon: Forehead skin redness or nausea
Rare: Forehead skin allergy

Hypoallergenic electrodes are available for users with a known acrylate allergy.

Cefaly Contraindications

Do not use Cefaly if you have the following:

Metallic or electronic implants in the head
A cardiac pacemaker
An implanted or wearable defibrillator
Pain of unknown origin

Talk to your healthcare provider before using Cefaly if you are pregnant, breastfeeding, have an implanted device, have a complex medical history, are changing medications, or are experiencing new or unusual symptoms. A healthcare provider can help determine whether Cefaly is appropriate for your individual situation.

How to Use Cefaly at Home

The getting started process is designed for self-administered treatment at home.

Initial Setup

Charge the device before first use. The initial charge takes approximately four hours.
Download the Cefaly Migraine Relief app if you are using Cefaly Connected in a supported region.
Pair the device through Bluetooth using the six-digit PIN located on the device.

Preparing for Treatment

Wash the forehead between and above the eyebrows with basic soap and water.
Dry the skin completely.
Avoid alcohol wipes, makeup remover, lotion cleansers, or moisturizers on the treatment area.
Place the electrode between and just above the eyebrows.
Attach Cefaly magnetically to the electrode.

Reclining or lying down can help maintain electrode adhesion during treatment.

Selecting a Program

Press the device button once for the 60-minute Acute program.
Press the button twice, with a pause between presses, for the 20-minute Prevent program.

For acute treatment, begin at the earliest sign of a migraine attack. For preventive treatment, use the Prevent program daily as directed.

What Treatment Feels Like

The stimulation intensity increases gradually during the first 14 minutes. Users commonly describe the sensation as tingling, prickling, vibrating, or a deeper pulsing feeling.

Treatment should remain noticeable but comfortable and should not feel painful. Cefaly Connected users can adjust or stabilize intensity through the app, and users can also control intensity with the device button.

Cefaly App, Coaching, and Support

The Cefaly app gives Cefaly Connected users additional tools for treatment control and migraine tracking.

App Features

Start, stop, and monitor Acute or Prevent sessions
Adjust treatment intensity
Log attacks, symptoms, triggers, and warning signs
Track environmental factors such as barometric pressure
Sync supported sleep and activity data
Generate reports for healthcare appointments

The app is informational and does not replace medical advice, diagnosis, or treatment.

Coaching and Customer Support

Cefaly offers free one-on-one calls with a Cefaly Coach in supported regions. Coaching can help with device setup, comfortable intensity selection, app use, electrode care, and troubleshooting.

Users can also contact customer support for assistance. Cefaly Connected, the app, and coaching are not currently available in the EU.

Cefaly Electrodes and Accessories

Cefaly uses reusable adhesive electrodes that attach the device to the forehead and conduct the stimulation.

Standard and Hypoallergenic Electrodes

Cefaly offers:

Standard electrodes: Intended for most users
Hypoallergenic electrodes: Recommended for users with a known acrylate allergy

Electrodes are sold in packs of three. Both types can be reused while they continue to adhere properly. The number of uses varies based on skin preparation, storage, activity during treatment, and electrode type. Standard electrodes generally provide more uses than hypoallergenic electrodes.

An electrode subscription provides 5% savings, free shipping, and delivery intervals of 30, 60, or 90 days.

Electrode Care

To support adhesion and consistent treatment:

Wash and dry the forehead before every session.
Handle the electrode by its edges.
Avoid touching the adhesive surface.
Recline or lie down during treatment when possible.
Replace the electrode on its plastic backing immediately after use.
Store it in the sealed electrode pouch at room temperature.
Stop reusing an electrode when it no longer adheres properly or becomes dirty or dry.

Why Cefaly Stands Out for At-Home Migraine Treatment

Cefaly combines drug-free acute and preventive migraine treatment in one prescription-free e-TNS device for adults. Its forehead placement directly targets the trigeminal nerve, and its two programs support both treatment during an attack and a daily preventive routine.

Cefaly is also supported by more than 20 years of research, more than 12 clinical trials, 18 peer-reviewed publications, and three pivotal randomized controlled trials. Cefaly Connected adds app-based control and migraine tracking in supported regions.

Direct purchases from the official website include a 90-day satisfaction guarantee for eligible products. HSA/FSA eligibility, financing options, insurance resources, coaching, customer support, and a certified provider network provide additional practical support.

For eligible veterans, Cefaly provides information about veterans benefits and VA healthcare coverage.

Individual results vary, and Cefaly does not cure migraine. Talk to a healthcare provider about persistent, changing, or unusual migraine symptoms and before making changes to an existing treatment plan.

Frequently Asked Questions

Is Cefaly covered by insurance or HSA/FSA?

Cefaly and its electrodes may qualify as HSA/FSA expenses, subject to plan rules. Insurance reimbursement varies by provider and plan. Cefaly offers reimbursement resources, but coverage is not guaranteed. Eligible veterans may receive Cefaly through VA healthcare benefits.

How does Cefaly feel during treatment?

Cefaly may feel like tingling, prickling, vibrating, or pulsing on the forehead. Intensity increases gradually during the first 14 minutes. The sensation should remain comfortable rather than painful.

Can Cefaly be used with migraine medication?

Because Cefaly is drug-free, it does not create drug-drug interactions. Talk to your healthcare provider before changing medication or combining treatments as part of an individualized migraine plan.

How long does Cefaly take to work?

The Acute program runs for 60 minutes. In the ACME study, 79% of patients experienced significant headache pain reduction after one hour. Preventive outcomes were evaluated after three months of compliant daily use in the PREMICE study. Individual results vary.

Is the Cefaly app available everywhere?

No. Product and service availability varies by region. Cefaly Connected, the Cefaly Migraine Relief app, and Cefaly coaching are not currently available in the EU.

Does Cefaly cure migraines?

No. Cefaly is an FDA-cleared device for acute and preventive migraine treatment, but it does not cure migraine. It is one tool that may be included in a broader migraine management plan.